MS studies enrolling now Use only provided promo materials - IRB approved ! Payment Terms NET60! Conversion Point: Referral (screener complete and zip submit) Allowed Methods of Promotion: Web Placement, Search, E-Mail, Social, Mobile (LP are optimized), Contextual, Native Restrictions: No Incent, No Adult, No Fraud, No Bot, No Content Locking, No Misleading Those who are eligible*: May receive payment up to $525, which varies by study May receive study-related care from local doctors at no cost May receive study medication at no cost Key Inclusion criteria: Adults, 18- 55 years of age Diagnosed with RMS One or more documented relapses within the 2 years before Screening Neurologically stable for ≥ 30 days prior to both Screening and Baseline Key Exclusion criteria: Patients meeting any of the following criteria are not eligible for inclusion in this study.   Participants diagnosed with progressive MS History or current diagnosis of tuberculosis Immunologic disorder other than MS or any other condition requiring oral, intravenous (IV), intramuscular, or intra-articular corticosteroid therapy, with the exception of well-controlled Type 2 diabetes mellitus or well controlled thyroid disease Targeting Sites: US Zips listed – more US sites and countries will be added 34607 33634 33952 45459 96817 33428 46256 32751 77030 19090 Additional Countries to Come Later: Canada, Germany, Italy, United Kingdom, Bulgaria, Czech Republic, Hungary, Poland, South Africa, Argentina, Australia

AdsMain